Maynard Um
-
-
-
-
-
-
-
CRISPR Therapeutics (CRSP) Ticks Higher on Takeover Speculation
-
-
-
-
-
-
-
CRISPR Therapeutics (CRSP) PT Lowered to $50 at Clear Street
-
-
-
-
-
-
-
BMO Capital on CRISPR Therapeutics (CRSP): 'We Continue to Highlight the Large Oppty of FXI Space'
-
-
-
-
-
-
-
CRISPR Therapeutics (CRSP) 30-day option implied volatility flat
-
-
-
-
-
-
-
Barclays Reiterates Equalweight Rating on CRISPR Therapeutics (CRSP)
-
-
-
-
-
-
-
Citizens JMP Reiterates Market Outperform Rating on CRISPR Therapeutics (CRSP)
-
-
-
-
-
-
-
CRISPR Therapeutics (CRSP) Announces Transition of Chief Operating Officer
-
341,965 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

